June 30, 2015 - ViewRay announced that the company has secured up to $50 million in debt financing from CRG (formerly Capital Royalty L.P.), a premier healthcare investment firm.
This debt is part of ViewRay's comprehensive financing strategy to optimize its capital structure and to provide the funding for driving its global expansion. Through the transaction with CRG, ViewRay will initially access $30 million of debt, which is interest-only for three years. This will enable the company to accelerate the worldwide commercialization of the MRIdian magnetic resonance imaging (MRI)-guided radiation therapy system and to retire $13 million of debt with less favorable terms. The company has the option to draw a further $20 million at its discretion upon achieving certain milestones.
For more information: www.viewray.com
March 30, 2026 
